Switching basal insulins in type 2 diabetes: practical recommendations for health care providers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching basal insulins in type 2 diabetes: practical recommendations for health care providers

Published:2017-12-27 Issue:2 Volume:130 Page:229-238
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Anderson Sarah L.¹^ORCID,Trujillo Jennifer M.¹^ORCID,Anderson John E.²,Tanenberg Robert J.³^ORCID

Affiliation:

1. Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA

2. The Frist Clinic, Nashville, TN, USA

3. Brody School of Medicine, Division of Endocrinology, East Carolina University, Greenville, NC, USA

Funder

Sanofi US, Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2018.1419048

Reference77 articles.

1. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary

3. The Treat-to-Target Trial

4. Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100);Clinical Diabetes;2023-03-28

2. Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database;Diabetes Therapy;2023-01-04

3. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin;Journal of Managed Care & Specialty Pharmacy;2022-03-30

4. Considerations for Insulin-Treated Type 2 Diabetes Patients During Hospitalization: A Narrative Review of What We Need to Know in the Age of Second-Generation Basal Insulin Analogs;Diabetes Therapy;2020-09-30

5. Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrations;Diabetes, Obesity and Metabolism;2020-01-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3